Eli Lilly Vowed To Offer Half-Priced Insulin, But Lawmakers’ Survey Finds Many Pharmacies Don’t Even Know It’s An Option

“Our report shows that Eli Lilly has failed to deliver on its promise to put a more-affordable insulin product on the shelves,” said Sen. Richard Blumenthal (D-Conn), who teamed with Sen. Elizabeth Warren (D-Mass.). The cost of insulin has become a stand-in for a larger battle of drug costs because the life-saving medication's price tag has skyrocketed. In other pharmaceutical news: a dwarfism drug, a bankrupt startup, a novel partnership, a Parkinson's treatment, and more.

from Kaiser Health News https://ift.tt/2PumzxF